Enantioselective synthesis of diversely substituted quaternary 1,4-benzodiazepin-2-ones and 1,4-benzodiazepine-2,5-diones

Journal of the American Chemical Society

Volumn 128, Issue 47, 2006, Pages 15215-15220

  Carlier, Paul R ^a   Zhao, Hongwu ^a   MacQuarrie Hunter, Stephanie L ^a   DeGuzman, Joseph C ^a   Hsu, Danny C ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDITY; AMINO ACIDS; BIOMEDICAL ENGINEERING; CONFORMATIONS; SUBSTITUTION REACTIONS; SYNTHESIS (CHEMICAL);

BENZODIAZEPINES; CHIRALITY; DEPROTONATION; MEDICINAL CHEMISTRY;

SCAFFOLDS;

1,4 BENZODIAZEPINE 2,5 DIONE DERIVATIVE; AMINO ACID; BENZODIAZEPIN 2 ONE DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CARBON; METHYL GROUP; NITROGEN;

ARTICLE; CHEMICAL REACTION; CHEMICAL STRUCTURE; CHIRALITY; CONFORMATION; ENANTIOSELECTIVITY; PROTON TRANSPORT; REACTION ANALYSIS; STRUCTURE ANALYSIS; SYNTHESIS;

ALKYLATION; BENZODIAZEPINES; MOLECULAR CONFORMATION; STEREOISOMERISM; THERMODYNAMICS;

EID: 33845211978     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja0640142     Document Type: Article

References (38)

1. Evans, B. E.; et al. J. Med. Chem. 1988, 31, 2235-2246.
2. Ellman, J. A. Acc. Chem. Res. 1996, 29, 132-143.
3. Boojamra, C. G.; Burow, K. M.; Thompson, L. A.; Ellman, J. A. J. Org. Chem. 1997, 62, 1240-1256.
4. Herpin, T. F.; Van Kirk, K. G.; Salvino, J. M.; Yu, S. T.; Labaudiniere, R. F. J. Comb. Chem. 2000, 2, 513-521.
5. Wu, Z.; Ercole, F.; FitzGerald, M.; Perera, S.; Riley, P.; Campbell, R.; Pham, Y.; Rea, P.; Sandanayake, S.; Mathieu, M. N.; Bray, A. M.; Ede, N. J. J. Comb. Chem. 2003, 5, 166-171.
6. Carlier, P. R.; Zhao, H.; DeGuzman, J.; Lam, P. C.-H. J. Am. Chem. Soc. 2003, 125, 11482-11483.
7. MacQuarrie-Hunter, S.; Carlier, P. R. Org. Lett. 2005, 7, 5305-5308.
8. Fuji, K.; Kawabata. T. Chem. - Eur. J. 1998, 4, 373-376.
9. Zhao, H.; Hsu, D. C.; Carlier, P. R. Synthesis 2005, 1-16.
10. The term chirality in the phrase "memory of chirality" originally coined by Fuji (Kawabata, T.; Yahiro, K.; Fuji, K. J. Am. Chem. Soc. 1991, 113, 9694-9696) properly refers to the sense of chirality, or configuration. Chirality is retained in the intermediates whether they racemize or remain enantiopure; the same is obviously true of the products. Perhaps a better term would be "memory of configuration".
11. Carlier, P. R.; Lam, P. C.-H.; DeGuzman, J.; Zhao, H. Tetrahedron: Asymmetry 2005, 16, 2998-3002.
12. Kawabata, T.; Kimura, Y.; Ito, Y.; Terashima, S. Tetrahedron Lett. 1986, 27, 6241-6244.
13. Kobayashi, Y.; Takemoto, Y.; Ito, Y.; Terashima, S. Tetrahedron Lett. 1990, 31, 3031-3034.
14. AbuSbeith, K.; Bleasdale, C.; Golding, B. T.; Kitson, S. L. Tetrahedron Lett. 1992, 55, 4807-4810.
15. Henneuse, C.; Boxus, T.; Tesolin, L.; Pantano, G.; Marchand-Brynaert, J. Synthesis 1996, 495-501.
16. Kice, J. L.; Rudzinski, J. J. J. Org. Chem. 1987, 52, 2414-2421.
17. Hart, B. R.; Rush, D. J.; Shea, K. J. J. Am. Chem. Soc. 2000, 122, 460-465.
18. Kahne, D.; Collum, D. B. Tetrahedron Lett. 1981, 22, 5011-5014.
19. Ogata, M.; Matsumoto, H.; Hirose, K. J. Med. Chem. 1977, 20, 776-781.
20. James, G. L.; Goldstein, J. L.; Brown, M. S.; Rawson, T. E.; Somers T. C.; McDowell, R. S.; Crowley, C. W.; Lucas, B. K.; Levinson, A. D.; Masters, J. C. Science 1993, 260, 1937-1942.
21. Selnick, H. G.; et al. J. Med. Chem. 1997, 40, 3865-3868.
22. Evans, D. A.; Britton, T. C.; Ellman, J. A.; Dorow, R. A. J. Am. Chem. Soc. 1990, 112, 4011-4030.
23. Evans, D. A.; Britton, T. C.; Dorow, R. L.; Dellaria, J. F. J. Am. Chem. Soc. 1986, 108, 6395-6397.
24. The chloro substituent in these 1,4-benzodiazepin-2-ones derives from the 2-amino-5-chlorobenzophenone starting material, a commercially available intermediate used in the production of diazepam.
25. One possible explanation for the need for excess base is that alkylation occurs more quickly on a KHMDS/potassium enolate mixed aggregate than it does on homomeric potassium enolates.
26. Kobayashi, Y.; Ito, Y.; Terashima, S. Bull. Chem. Soc. Jpn. 1989, 62, 3041-3042.
27. Lam, P. C.-H.; Carlier, P. R. J. Org. Chem. 2005, 70, 1530-1538.
28. This dihedral angle has the same sign as the C2-C3-N4-C5 dihedral, which has historically (Konowal, A.; Snatzke, G.; Alebic-Kolbah, T.; Kajfez, F.; Rendic, S.; Sunjic, V. Biochem. Pharm. 1979, 28, 3109-3113) been used to designate the sense of conformational chirality of the benzodiazepine ring.
29. Linscheid, P.; Lehn, J.-M. Bull. Chim. Soc. Fr. 1967, 992-997.
30. Booth, H.; Dixon, J. M.; Khedhair, K. A. Tetrahedron 1992, 48, 6161-6174.
31. Eliel, E. L.; Wilen, S. H. In Stereochemistry of Organic Molecules; John Wiley & Sons: New York, 1994; pp 696-697.
32. Wright, W. B.; Brabander, H. J.; Greenblatt, E. N.; Day, I. P.; Hardy, R. A., Jr. J. Med. Chem. 1978, 21, 1087-1089.
33. Pen̄a, M. R.; Stille, J. K. J. Am. Chem. Soc. 1989, 111, 5417-5424.
34. Dyatkin, A. B.; Maryanoff, B. E. Org. Prep. Proc. Int 2002, 34, 652-655.
35. Seebach, D.; Boes, M.; Naef, R.; Schweizer, W. B. J. Am. Chem. Soc. 1983, 105, 5390-5398.
36. Kawabata, T.; Chen, J.; Suzuki, H.; Nagae, Y.; Kinoshita, T.; Chancharunee, S.; Fuji, K. Org. Lett. 2000, 2, 3883-3885.
37. Kawabata, T.; Chen, J.; Suzuki, H.; Fuji, K. Synthesis 2005, 1368-1377.
38. Consistent with this analysis, preliminary deprotonation/trapping studies of N-i-Pr-1,4-benzodiazepin-2-one (S)-1d indicate the potassium enolate has a racemization barrier of 18 kcal/mol (258 K). In contrast, the same technique indicates only a 12.5 kcal/mol barrier (173 K) for the potassium enolate derived from N-i-Pr-1,4-benzodiazepine-2,5-dione (S)-3d (P. C.-H. Lam, S. L. MacQuarrie-Hunter, and P. R. Carlier, unpublished work).